Dr. William Ting is a skilled dermatologic and reconstructive surgeon and is a fellow of the American Society of Dermatologic Surgery. He has tremendous experience in surgical and procedural dermatology. He has completed a surgically-oriented dermatology residency at the University of Iowa where he operated on countless Iowan farmers and families with skin cancers on face and neck as well as other parts of the body. As a result, at the end of his dermatology residency, he had substantially greater amount of surgical experience than a typical dermatology graduate in the U.S.

He had acquired significant Mohs micrographic surgery experience while working with Drs. Duane Whitaker, Christopher Arpey and Daniel Davis while at University of Iowa. He is a member of the American Society of Mohs Surgery.

Dr. Ting and Dr. Tomciks' skill in tumescent liposuction arose from their apprenticeship with Dr. Jeffrey Klein, who invented and published numerous peer-reviewed medical articles on tumescent liposuction.

Dr. Ting and Dr. Tomcik have become the early pioneers of fractional CO2 resurfacing laser. With Dr. Ting's Electrical Engineering undergraduate background at UC Berkeley and understanding of the laser optics, he has mastered the subtleties of cosmetic and therapeutic lasers, particularly fractional CO2 laser enabling him to expertly deliver the most optimal resurfacing for patients who need to reverse years of photoaging and acne scarring.

FACTOIDS about SKIN CANCER

Skin cancers can be minimized via strict daily sun protection, regular visits to a board-certified dermatologist and modalities to reverse sun damage (see Preventive Dermatology page)

• 1 in 3 Caucasian-Americans will have a nonmelanoma skin cancer (NMSC) in his or her lifetime.

• Basal cell carcinoma (BCC) derives from malignant proliferation of the bottom layer of the epidermis, known as the basal layer. It is the most common skin cancer, period, for Caucasian-Americans.

• Squamous cell carcinoma (SCC)arises from malignant proliferation of the top layers of the epidermis. It is the second most common NMSC, tends to be more aggressive and grows more quickly than BCC. More than 10% of SCC may metastasize if left untreated for several months.

• Malignant Melanoma is triggered by malignant transformation of pigment-producing cells of the epidermis known as melanocytes.
• Risk of melanoma is 1 in 33 Americans in year 2007/8.
• Invasive melanoma is the 6th most common cancer in men and women.
• Melanoma is the second most common cancer for women aged 20-29 years.
• 5-year survival of melanoma-in-situ, if caught early, is better than 95%.
• Every first-degree relative of someone with history of melanoma must get a head-to-toes skin check once a year as the risk of melanoma is significantly higher than the general population.
• Click for MORE Magazine's article on 'What you need to know about Malignant melanoma'.